HUP0200940A3 - Use of glycopeptide antibiotic for treatment of streptococcus pneumoniae infections and pharmaceutical compositions containing them - Google Patents
Use of glycopeptide antibiotic for treatment of streptococcus pneumoniae infections and pharmaceutical compositions containing themInfo
- Publication number
- HUP0200940A3 HUP0200940A3 HU0200940A HUP0200940A HUP0200940A3 HU P0200940 A3 HUP0200940 A3 HU P0200940A3 HU 0200940 A HU0200940 A HU 0200940A HU P0200940 A HUP0200940 A HU P0200940A HU P0200940 A3 HUP0200940 A3 HU P0200940A3
- Authority
- HU
- Hungary
- Prior art keywords
- treatment
- pharmaceutical compositions
- compositions containing
- streptococcus pneumoniae
- glycopeptide antibiotic
- Prior art date
Links
- 241000193998 Streptococcus pneumoniae Species 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 title 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 title 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13225899P | 1999-05-03 | 1999-05-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0200940A2 HUP0200940A2 (en) | 2002-08-28 |
| HUP0200940A3 true HUP0200940A3 (en) | 2002-10-28 |
Family
ID=22453188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0200940A HUP0200940A3 (en) | 1999-05-03 | 2000-04-19 | Use of glycopeptide antibiotic for treatment of streptococcus pneumoniae infections and pharmaceutical compositions containing them |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP1175222B1 (hu) |
| JP (1) | JP2002543146A (hu) |
| KR (1) | KR100757165B1 (hu) |
| CN (1) | CN1349407A (hu) |
| AR (1) | AR023827A1 (hu) |
| AT (1) | ATE284702T1 (hu) |
| AU (1) | AU774647B2 (hu) |
| BR (1) | BR0010244A (hu) |
| CA (1) | CA2372790A1 (hu) |
| CZ (1) | CZ296127B6 (hu) |
| DE (1) | DE60016734T2 (hu) |
| DZ (1) | DZ3039A1 (hu) |
| EA (1) | EA004295B1 (hu) |
| HK (1) | HK1044707B (hu) |
| HR (1) | HRP20010808A2 (hu) |
| HU (1) | HUP0200940A3 (hu) |
| IL (2) | IL145582A0 (hu) |
| MY (1) | MY123542A (hu) |
| NO (1) | NO20015291L (hu) |
| NZ (1) | NZ514467A (hu) |
| PE (1) | PE20010292A1 (hu) |
| PL (1) | PL353444A1 (hu) |
| SK (1) | SK285970B6 (hu) |
| SV (1) | SV2002000065A (hu) |
| TR (1) | TR200103211T2 (hu) |
| TW (1) | TWI255716B (hu) |
| UA (1) | UA73937C2 (hu) |
| WO (1) | WO2000066144A2 (hu) |
| ZA (1) | ZA200108013B (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013202360B2 (en) * | 2008-08-30 | 2016-03-24 | Melinta Therapeutics, Inc. | Methods of treatment using single doses of oritavancin |
| CN102215858A (zh) * | 2008-08-30 | 2011-10-12 | 塔尔甘塔治疗公司 | 使用单剂量奥利万星的治疗方法 |
| US20160206688A1 (en) * | 2013-08-26 | 2016-07-21 | The Medicines Company | Methods for treating bacteremia and osteomyelitis using oritavancin |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5840684A (en) * | 1994-01-28 | 1998-11-24 | Eli Lilly And Company | Glycopeptide antibiotic derivatives |
-
2000
- 2000-04-19 WO PCT/US2000/008737 patent/WO2000066144A2/en not_active Application Discontinuation
- 2000-04-19 JP JP2000615028A patent/JP2002543146A/ja not_active Withdrawn
- 2000-04-19 DE DE60016734T patent/DE60016734T2/de not_active Expired - Fee Related
- 2000-04-19 SK SK1557-2001A patent/SK285970B6/sk not_active IP Right Cessation
- 2000-04-19 BR BR0010244-0A patent/BR0010244A/pt not_active Application Discontinuation
- 2000-04-19 HU HU0200940A patent/HUP0200940A3/hu not_active IP Right Cessation
- 2000-04-19 EA EA200101171A patent/EA004295B1/ru not_active IP Right Cessation
- 2000-04-19 UA UA2001117510A patent/UA73937C2/uk unknown
- 2000-04-19 CA CA002372790A patent/CA2372790A1/en not_active Abandoned
- 2000-04-19 CN CN00807028A patent/CN1349407A/zh active Pending
- 2000-04-19 AU AU43292/00A patent/AU774647B2/en not_active Ceased
- 2000-04-19 PL PL00353444A patent/PL353444A1/xx not_active IP Right Cessation
- 2000-04-19 IL IL14558200A patent/IL145582A0/xx unknown
- 2000-04-19 TR TR2001/03211T patent/TR200103211T2/xx unknown
- 2000-04-19 CZ CZ20013949A patent/CZ296127B6/cs not_active IP Right Cessation
- 2000-04-19 AT AT00923113T patent/ATE284702T1/de not_active IP Right Cessation
- 2000-04-19 KR KR1020017014017A patent/KR100757165B1/ko not_active IP Right Cessation
- 2000-04-19 EP EP00923113A patent/EP1175222B1/en not_active Expired - Lifetime
- 2000-04-19 NZ NZ514467A patent/NZ514467A/en unknown
- 2000-05-02 SV SV2000000065A patent/SV2002000065A/es not_active Application Discontinuation
- 2000-05-02 AR ARP000102101A patent/AR023827A1/es unknown
- 2000-05-02 DZ DZ000081A patent/DZ3039A1/xx active
- 2000-05-02 PE PE2000000405A patent/PE20010292A1/es not_active Application Discontinuation
- 2000-05-02 TW TW089108318A patent/TWI255716B/zh not_active IP Right Cessation
- 2000-05-03 MY MYPI20001904A patent/MY123542A/en unknown
-
2001
- 2001-09-24 IL IL145582A patent/IL145582A/en not_active IP Right Cessation
- 2001-09-28 ZA ZA200108013A patent/ZA200108013B/xx unknown
- 2001-10-29 NO NO20015291A patent/NO20015291L/no not_active Application Discontinuation
- 2001-10-31 HR HR20010808A patent/HRP20010808A2/hr not_active Application Discontinuation
-
2002
- 2002-06-26 HK HK02104765.3A patent/HK1044707B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9802525D0 (en) | Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections | |
| HUP0103874A3 (en) | Use of antibiotics and pharmaceutical compositions comprising thereof | |
| IL148641A0 (en) | Topical treatment of streptococcal infections | |
| HUP0002662A3 (en) | Pharmaceutical compositions containing lysostaphin alone or in combination with an antibiotic for the treatment of staphylococcal infections | |
| HUP0301815A3 (en) | Mono and disaccharide-based pharmaceutical composition for infections and other diseases and prophylactic and therapeutic treatment | |
| HUP0300393A3 (en) | C-aryl glucoside sglt2 inhibitors and their use and pharmaceutical compositions containing them | |
| EP1173193A4 (en) | DES-LEUCYL GLYCOPEPTIDE ANTIBIOTICS AND METHOD OF PREPARATION | |
| IL147217A0 (en) | New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain | |
| HUP0402126A3 (en) | Dual action antibiotics and pharmaceutical compositions containing them | |
| IL145282A0 (en) | Compositions and methods for treatment of staphylococcal infection | |
| IL153875A0 (en) | Macrolide formulations for inhalation and methods of treatment of endobronchial infections | |
| HUP0300370A3 (en) | 2-hydroxy-mutilin carbamate derivatives of antibacterial effect process for preparation and pharmaceutical compositions containing them | |
| HUP0201067A3 (en) | 6-o-substituted macrolides having antibacterial activity, pharmaceutical compositions containing them, their use and process for preparation of the compounds | |
| HUP0004579A2 (hu) | Antibakteriális hatású, a 3'-N-pozícióban módosított szerkezetű 6-0-szubsztituált-eritromicin-ketolid-származékok és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0401596A3 (en) | Cross-linked glycopeptide-cephalosporin antibiotics and pharmaceutical compositions containing them | |
| HUP0201116A3 (en) | Erythromycin derivatives and pharmaceutical compositions containing them and their use | |
| AU2000255628A1 (en) | Formulation comprising thymol useful in the treatment of drug resistant bacterial infections | |
| AU5029700A (en) | Glycopeptide antibacterial compounds, compositions containing same and methods of using same | |
| HUP0300402A3 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them | |
| HUP0200940A2 (en) | Use of glycopeptide antibiotic for treatment of streptococcus pneumoniae infections and pharmaceutical compositions containing them | |
| HUP0102836A3 (en) | Use of oxazolidinones for preparation of pharmaceutical compositions suitable for treating eye infections | |
| AU2001257163A1 (en) | Glycopeptide antibacterial compounds and methods of using same | |
| HUP0003409A3 (en) | Use of macrolide antibiotics for the prepartion of pharmaceutical compositions treating or preventing coccidiosis | |
| AU2001268737A1 (en) | Methods to screen for antibiotic agents and their use in treatment of opportunistic infections | |
| HUP9802450A3 (en) | Use of prostane derivatives and the combination thereof for preparing pharmaceutical compositions for use in treatment of bacterial infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RH9A | Decision on the lapse of patent protection withdrawn | ||
| FD9A | Lapse of provisional protection due to non-payment of fees |